Imaging of sleep disorders in pre-Parkinsonian syndromes

被引:4
|
作者
Ota, Yoshiaki [1 ]
Kanel, Prabesh [2 ,3 ,4 ]
Bohnen, Nicolaas [2 ,3 ,4 ,5 ,6 ]
机构
[1] Univ Michigan, Div Neuroradiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Div Nucl Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Morris K Udall Ctr Excellence Parkinsons Dis Res, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Parkinsons Fdn, Res Ctr Excellence, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[6] VAAAHS, GRECC Neurol Serv, Ann Arbor, MI USA
关键词
cardiac metaiodobenzylguanidine; diffusion tensor imaging; dopamine transporter imaging; single-photon emission computerized tomography; functional MRI; neuromelanin-sensitive MRI; Parkinson's disease; PET; prodromal clinical marker; rapid eye movement sleep disorder; PREDICTS EARLY TRANSITION; BEHAVIOR DISORDER; COERULEUS/SUBCOERULEUS COMPLEX; NEURODEGENERATIVE DISEASE; FUNCTIONAL CONNECTIVITY; DIFFERENTIAL-DIAGNOSIS; PRODROMAL DEMENTIA; SUBSTANTIA-NIGRA; GRAY-MATTER; BLOOD-FLOW;
D O I
10.1097/WCO.0000000000001084
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Neuroimaging has been advanced in the last years and enabled clinicians to evaluate sleep disorders, especially isolated rapid eye movement sleep disorder (iRBD), which can be seen in alpha-synucleinopathies. iRBD is the best prodromal clinical marker for phenoconversion to these neurodegenerative diseases. This review aims to provide an update on advanced neuroimaging biomarkers in iRBD. Recent findings Advanced structural MRI techniques, such as diffusion tensor imaging and functional MRI, neuromelanin-sensitive MRI, and scintigraphic neuroimaging such as cholinergic PET, dopamine transporter imaging - single-photon emission computerized tomography, perfusional single-photon emission computerized tomography, and cardiac metaiodobenzylguanidine can provide diagnostic and prognostic imaging biomarkers for iRBD, in isolation and more robustly when combined. New advanced neuroimaging can provide imaging biomarkers and aid in the appropriate clinical assessment and future therapeutic trials.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 50 条
  • [31] Transcranial brain sonography for Parkinsonian syndromes
    Bor-Seng-Shu, Edson
    Paschoal, Fernando M.
    Almeida, Kelson J.
    De Lima Oliveira, Marcelo
    Nogueira, Ricardo C.
    Teixeira, Manoel J.
    Walter, Uwe
    JOURNAL OF NEUROSURGICAL SCIENCES, 2019, 63 (04) : 441 - 449
  • [32] Neurorehabilitation in parkinsonian syndromes
    Gracies, J. -M.
    REVUE NEUROLOGIQUE, 2010, 166 (02) : 196 - 212
  • [33] Diffusion Tensor Imaging Marks Dopaminergic and Serotonergic Lesions in the Parkinsonian Monkey
    Metereau, Elise
    Beaudoin-Gobert, Maude
    Duperrier, Sandra
    Thobois, Stephane
    Tremblay, Leon
    Sgambato-Faure, Veronique
    MOVEMENT DISORDERS, 2018, 33 (02) : 298 - 309
  • [34] Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates
    Niethammer, Martin
    Eidelberg, David
    IMAGING IN MOVEMENT DISORDERS: IMAGING IN NON-PARKINSONIAN MOVEMENT DISORDERS AND DEMENTIAS, PT 2, 2019, 144 : 143 - 184
  • [35] Practical Overview of 123I-Ioflupane Imaging in Parkinsonian Syndromes
    Mercer, Megan K.
    Revels, Jonathan W.
    Blacklock, Lisa C.
    Banks, Kevin P.
    Johnson, Lester S.
    Lewis, David H.
    Kuo, Phillip H.
    Wilson, Shannon
    Elojeimy, Saeed
    RADIOGRAPHICS, 2024, 44 (02)
  • [36] The Utility of Neuroimaging in the Differential Diagnosis of Parkinsonian Syndromes
    Holtbernd, Florian
    Eidelberg, David
    SEMINARS IN NEUROLOGY, 2014, 34 (02) : 202 - 209
  • [37] Sleep Disorders in Parkinsonian Macaques: Effects of L-Dopa Treatment and Pedunculopontine Nucleus Lesion
    Belaid, Hayat
    Adrien, Joelle
    Laffrat, Elodie
    Tande, Dominique
    Karachi, Carine
    Grabli, David
    Arnulf, Isabelle
    Clark, Stewart D.
    Drouot, Xavier
    Hirsch, Etienne C.
    Francois, Chantal
    JOURNAL OF NEUROSCIENCE, 2014, 34 (27) : 9124 - 9133
  • [38] Imaging Parkinsonian Pathology in Substantia Nigra with MRI
    Huddleston D.E.
    Langley J.
    Dusek P.
    He N.
    Faraco C.C.
    Crosson B.
    Factor S.
    Hu X.P.
    Current Radiology Reports, 6 (4)
  • [39] 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes
    Mittal, Bhagwant R.
    Sood, Apurva
    Shukla, Jaya
    Vatsa, Rakhee
    Bhusari, Priya
    Shree, Ritu
    Mehta, Sahil
    Goyal, Manoj
    Modi, Manish
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (04) : 312 - 318
  • [40] Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
    Pont-Sunyer, Claustre
    Iranzo, Alex
    Gaig, Carles
    Fernandez-Arcos, Ana
    Vilas, Dolores
    Valldeoriola, Francesc
    Compta, Yaroslau
    Fernandez-Santiago, Ruben
    Fernandez, Manel
    Bayes, Angels
    Calopa, Matilde
    Casquero, Pilar
    de Fabregues, Oriol
    Jauma, Serge
    Puente, Victor
    Salamero, Manel
    Marti, Maria Jose
    Santamaria, Joan
    Tolosa, Eduard
    PLOS ONE, 2015, 10 (07):